Additional file 2: of Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Tables S1. Pathological and Biological Features of Primary PDAC Cell Lines from Patient-Derived Xenograft Tumors*. Table S2. Adverse Effects of H-Zt/g4-MMAE on blood leukocyte and erythrocytes in Cynomolgus monkey. Table S3. Effect of H-Zt/g4-MMAE in vivo on various enzymatic activities in blood samples collected from cynomolgus monkeys. (PDF 663 kb)